Skip to main content

In Brief This Week: iGenix, Illumina; Sigma-Aldrich; Becton Dickinson; UK's National Cancer Research Institute; SRU Biosystems

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Seattle-based iGenix has been named an Illumina certified service provider for the BeadXpress platform. iGenix said that it specializes in biomarker evaluation and helps clients develop new diagnostic assays for the BeadXpress platform.


Sigma-Aldrich said this week that its board of directors has declared a quarterly cash dividend of $.16 per share to be payable on Dec. 15 to shareholders of record on Dec. 1.


Becton Dickinson sold $1 billion worth of senior notes this past week. The firm sold $700 million of 3.25 percent notes due Nov. 12, 2020, and $300 million of 5 percent notes due Nov. 12, 2040.


The UK's National Cancer Research Institute has launched the UK Prostate Cancer Sample Collection Database. NCRI said that in addition to 10,000 biological samples taken from men in the UK with and without prostate cancer, the biobank will also hold other materials for research, including DNA, RNA, blood, and urine. The biobank will hold both clinical and molecular data.


SRU Biosystems is offering its newest label-free BIND Scanner to an academic or non-profit lab that wins its annual Label-free Technology Award. The Woburn, Mass.-based firm said the recipient of the award will be chosen based on "scientific merit, novelty of research, and the promise of advancing science and medicine using label-free technology.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.